Sage Therapeutics shares owned by Bank of New York Mellon
Quarter-by-quarter ownership of Sage Therapeutics (SAGE) shares owned by Bank of New York Mellon
from 13F filings
Historical chart of Bank of New York Mellon investment in Sage Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Sage Therapeutics held by Bank of New York Mellon consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Sage Therapeutics by Bank of New York Mellon
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-12-31 | $931k | 171k | 5.43 |
| 2024-09-30 | $1.3M | 181k | 7.22 |
| 2024-06-30 | $2.4M | 219k | 10.86 |
| 2024-03-31 | $3.4M | 181k | 18.74 |
| 2023-12-31 | $4.2M | 196k | 21.67 |
| 2023-09-30 | $4.8M | 233k | 20.58 |
| 2023-06-30 | $11M | 236k | 47.02 |
| 2023-03-31 | $11M | 249k | 41.96 |
| 2022-12-31 | $9.5M | 250k | 38.14 |
| 2022-09-30 | $15M | 364k | 40.00 |
| 2022-06-30 | $11M | 352k | 32.15 |
| 2022-03-31 | $12M | 353k | 33.24 |
| 2021-12-31 | $14M | 343k | 41.46 |
| 2021-09-30 | $0 | 253k | 0.00 |
| 2021-06-30 | $16M | 275k | 56.81 |
| 2021-03-31 | $15M | 199k | 74.85 |
| 2020-12-31 | $18M | 207k | 86.50 |
| 2020-09-30 | $12M | 204k | 61.12 |
| 2020-06-30 | $8.7M | 207k | 41.86 |
| 2020-03-31 | $6.0M | 208k | 28.72 |
| 2019-12-31 | $39M | 536k | 72.19 |
| 2019-09-30 | $134M | 953k | 140.29 |
| 2019-06-30 | $218M | 1.2M | 183.07 |
| 2019-03-31 | $233M | 1.5M | 159.05 |
| 2018-12-31 | $175M | 1.8M | 95.76 |
| 2018-09-30 | $219M | 1.5M | 141.26 |
| 2018-06-30 | $245M | 1.6M | 156.53 |
| 2018-03-31 | $234M | 1.5M | 161.07 |
| 2017-12-31 | $267M | 1.6M | 164.71 |
| 2017-06-30 | $158M | 2.0M | 79.64 |
| 2017-03-31 | $146M | 2.1M | 71.06 |
| 2016-12-31 | $36M | 711k | 51.06 |
| 2016-09-30 | $6.3M | 137k | 46.05 |
| 2016-06-30 | $3.1M | 104k | 30.13 |